BioSpace News Archive

Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended June 30, 2020. Net revenues for the quarter are expected to be $1.6 million, a decrease of approximately 33% compared

Evotec SE announced that Evotec has added significant opportunity for further, long-term growth of its Toulouse-based operations by taking over “Biopark by Sanofi”.

APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based cell therapy APN401 targeting solid tumors and secures manufacturing for upcoming clinical trials

Ventilator associated pneumonia is an intensive care unit for acquired infection.

Sleep apnea is a life-threatening and serious sleep disorder that generally occurs when an individual’s breathing is disturbed during sleep.

Newborns are more prone to infections, which may occur at any time from the first day of life.

Infusion therapy involves direct delivery of medication in the bloodstream through intravenous route for immediate relief of pain or in case where a patient is unable to swallow medication.

VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, announces the completion of a €32 million Series B financing round.

Transparency Market Research has published a new report on the systemic lupus erythematosus treatment market for the forecast period of 2019–2027.

The global skin care devices market is considered as a highly competitive market with a large number of local and international players operating worldwide.